Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Circulation. Heart Failure|November 16, 2024
Natural Language Processing to Adjudicate Heart Failure Hospitalizations in Global Clinical TrialsPablo M Marti-Castellote, Christopher Reeder, Brian Claggett, et al.
European Heart Journal|May 30, 2026
Prevention of heart failureMassimo Piepoli, Giuseppe Rosano, Ana Abreu, et al.
European Journal of Heart Failure|August 26, 2023
Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trialMaria Pabon, Brian L Claggett, Xiaowen Wang, et al.
European Journal of Heart Failure|May 15, 2024
Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose-lowering therapy: A pre-specified analysis of the DELIVER trialMats Christian Højbjerg Lassen, John W Ostrominski, Silvio E Inzucchi, et al.
JAMA Cardiology|November 3, 2022
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Randomized Clinical TrialFinnian R Mc Causland, Brian L Claggett, Muthiah Vaduganathan, et al.
European Journal of Heart Failure|September 8, 2022
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of CardiologyAntoni Bayes-Genis, Alberto Aimo, Pardeep Jhund, et al.
European Journal of Heart Failure|March 17, 2025
How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESCDavide Stolfo, Massimo Iacoviello, Ovidiu Chioncel, et al.
JAMA Cardiology|November 12, 2023
Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical TrialFinnian R Mc Causland, Brian L Claggett, Muthiah Vaduganathan, et al.
European Journal of Heart Failure|May 1, 2021
Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of CardiologyGiuseppe M C Rosano, Brenda Moura, Marco Metra, et al.
European Journal of Heart Failure|April 9, 2026
European Journal of Heart Failure International Expert Position Paper Utilisation, Optimisation, and Clinical Benefits of Steroidal Mineralocorticoid Receptor Antagonists in Heart Failure with a Reduced Ejection FractionMichael Böhm, Jabir Abdullakutty, Johann Bauersachs, et al.
Pageof 4